Defects in trafficking bridge Parkinson's disease pathology and genetics.
about
Genetic analysis of the TMEM230 gene in Chinese Han patients with Parkinson's diseaseTwo-Pore Channels and Parkinson's Disease: Where's the Link?VPS35, the Retromer Complex and Parkinson's Disease.Novel approach for accurate tissue-based protein colocalization and proximity microscopy.Interleukin-6 regulates iron-related proteins through c-Jun N-terminal kinase activation in BV2 microglial cell linesAutophagy and Microglia: Novel Partners in Neurodegeneration and Aging.Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.Internalization, axonal transport and release of fibrillar forms of alpha-synuclein.The many ways tissue phagocytes respond to dying cells.Autophagy in neurodegenerative diseases: pathogenesis and therapy.The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.AAV-PHP.B-Mediated Global-Scale Expression in the Mouse Nervous System Enables GBA1 Gene Therapy for Wide Protection from Synucleinopathy.Progress toward an integrated understanding of Parkinson's disease.Food-Derived Antioxidant Polysaccharides and Their Pharmacological Potential in Neurodegenerative Diseases.Prescription database analyses indicates that the asthma medicine montelukast might protect against dementia: a hypothesis to be verified.Deviant lysosomal Ca2+ signalling in neurodegeneration. An introduction.Neurodegenerative disease: models, mechanisms, and a new hope.The Parkinson's disease-associated protein DJ-1 plays a positive nonmitochondrial role in endocytosis in Dictyostelium cells.Reduced Abundance and Subverted Functions of Proteins in Prion-Like Diseases: Gained Functions Fascinate but Lost Functions Affect Aetiology.Vertebrate food products as a potential source of prion-like α-synuclein.Running wheel exercise reduces α-synuclein aggregation and improves motor and cognitive function in a transgenic mouse model of Parkinson's disease.Defective trafficking of Kv2.1 channels in MPTP-induced nigrostriatal degeneration.Synaptic phosphorylated α-synuclein in dementia with Lewy bodies.Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.Convergent pathways in Parkinson's disease.Adapting Secretory Proteostasis and Function Through the Unfolded Protein Response.Neuronal lysosomal dysfunction releases exosomes harboring APP C-terminal fragments and unique lipid signatures.Pla2g6 Deficiency in Zebrafish Leads to Dopaminergic Cell Death, Axonal Degeneration, Increased β-Synuclein Expression, and Defects in Brain Functions and Pathways.Vaccination strategies in tauopathies and synucleinopathies.Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation.Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice.Imaging cellular trafficking processes in real time using lysosome targeted up-conversion nanoparticles.Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson's Disease Models.Current perspective of mitochondrial biology in Parkinson's disease.Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease.Neuronal lysosomes.Modeling Parkinson's Disease in Drosophila: What Have We Learned for Dominant Traits?Targeting energy metabolism via the mitochondrial pyruvate carrier as a novel approach to attenuate neurodegeneration.MiR-212 Attenuates MPP⁺-Induced Neuronal Damage by Targeting KLF4 in SH-SY5Y Cells.The expression of KATP channel subunits in alpha-synuclein-transfected MES23.5 cells.
P2860
Q33682386-AC14E0FF-DBA1-4295-896F-599A6B6242F3Q33703425-0772C842-417E-4049-B0B2-79426914B92CQ33708940-307E46B3-F49C-4826-823E-DB4062FDE59EQ33753090-04CF33EB-5D04-4109-957E-08224E7317C1Q33866033-0F324151-2EF0-487A-8523-BAA8DD35B704Q37729235-16A51FBA-F4DF-45B0-866E-615D8132CC22Q38684097-75288A8E-1B3B-4010-9F94-8060396EB854Q38890982-321D9C3F-E47C-4CC9-BB06-A509493D0834Q39277496-B8365D8E-3DB4-4E6D-8A6F-7DD0BE0C6AA3Q39432638-33936E27-DE7A-462F-94A8-D73E5AA2BC07Q39445835-A16CF3D0-2FD9-4AD7-B006-8CAB09BC3FAEQ40052760-CA97E5F8-C171-47BC-83F5-953E43DF6F38Q41012014-EDC2C0FA-0FC2-4CDF-B361-5607500200D3Q41195586-5BEA22E0-3A3F-4399-A3BE-4B39855E649BQ41585770-FAB3F6D8-0EBC-443A-AF6F-96121EC39700Q42257818-1D3576FA-60CB-40F9-9A42-A1ECFA015791Q42344614-3559EC91-9CDD-4D0C-B328-F441E53A7BE7Q44524559-89B2EB5F-9553-49E7-96D4-21BA77B25191Q44607866-DDD80326-B42E-4ED3-9532-D0139D478BEDQ46252338-6232878E-A5C8-4813-A534-B102D9598A41Q47260625-5B0C01C6-E7E8-426D-8A37-70370BC5381EQ47267039-F17E7CA7-C950-4447-98BD-01F915733157Q47362946-7FECE407-25A7-42E0-8E00-92D84CC37F9EQ47593688-CAFAAF7B-9AD5-4D24-AC91-AFAB03A046CDQ47612330-9F6EDEC9-3C1B-4906-8A60-8C85D7252552Q47774233-3F2C8A63-E0A7-49EC-A545-35F3904342B2Q47853126-06D4BC25-1120-46C1-90FD-DA634CE8E575Q47854549-D883898D-CB84-4597-A95F-E9B1848EA5C7Q47860105-35652A94-B498-403E-B5C3-FA75CDD3783CQ48192270-F4251C97-3AB7-4C22-BC18-B58B10F7B70FQ49545058-16889106-3555-4C77-B295-4FB701CA7537Q50050053-DC8FCBD4-0BE1-4AAD-BC49-61563628AB65Q51738958-4336247A-5B0F-4564-A7B4-5CEB4808E961Q52351688-F123A7B6-6BB5-43C4-A70B-BB1EA68AAB89Q52363911-6AF895F2-59D7-40E6-B45B-4100E6C7D7B9Q52601345-3E6D8AA5-77B0-4D52-AC20-77AC77CD2024Q54114687-DA585627-21E3-4F19-B92E-53BB0255C861Q54916848-9622B66D-A9E2-4E1E-8BFC-07C93526D61BQ55021223-FF776BCB-20B9-405F-8F0A-6504D871ED33Q55283965-A9FBD1A7-27A9-4FF4-8F8D-8A65AA036BFF
P2860
Defects in trafficking bridge Parkinson's disease pathology and genetics.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Defects in trafficking bridge Parkinson's disease pathology and genetics.
@en
Defects in trafficking bridge Parkinson's disease pathology and genetics.
@nl
type
label
Defects in trafficking bridge Parkinson's disease pathology and genetics.
@en
Defects in trafficking bridge Parkinson's disease pathology and genetics.
@nl
prefLabel
Defects in trafficking bridge Parkinson's disease pathology and genetics.
@en
Defects in trafficking bridge Parkinson's disease pathology and genetics.
@nl
P2860
P356
P1433
P1476
Defects in trafficking bridge Parkinson's disease pathology and genetics.
@en
P2093
Aaron D Gitler
Asa Abeliovich
P2860
P2888
P304
P356
10.1038/NATURE20414
P407
P577
2016-11-09T00:00:00Z